Behcet disease is a multisystem vasculitis characterized by mucosal aphthosis, primarily in the oral and genital mucosa. Only a few cases of involvement of the nasal mucosa have been reported in the literature, and its true prevalence is not known. Weconducted a cross-sectional study of 400 consecutivelypresenting patients with confirmed Behcet disease (according to classification-tree criteria) to determine the incidence of nasal mucosal involvement, to identify itsparticularcharacteristics, and to determine if there are any statistically significant differences in clinical and paraclinical parameters between Behietdisease patientswith nasalinvolvement and those without. To the best of our knowledge, this is the first systematic evaluation of nasal involvement in patients with Behcet disease to bepublished in theliterature. Data analysis was performed with Statistical Package for the Social Sciences software (SPSS), anda confidence interval (Cl) at 95% wascalculatedfor each finding. Involvement of the nasal mucosa was seen in 31 of the 400 patients (7.8%; Cl: 5.1 to 10.5). Among those 31 patients, the most common nasalsymptom was dysosmia, which was seen in 15 patients (3.8 % of the totalpopulation; CI: 1.9 to 5.7);
Behcet disease is a multisystem vasculitis characterized by mucosal aphthosis, primarily in the oral and genital mucosa. Only a few cases of involvement of the nasal mucosa have been reported in the literature, and its true prevalence is not known. Weconducted a cross-sectional study of 400 consecutivelypresenting patients with confirmed Behcet disease (according to classification-tree criteria) to determine the incidence of nasal mucosal involvement, to identify itsparticularcharacteristics, and to determine if there are any statistically significant differences in clinical and paraclinical parameters between Behietdisease patientswith nasalinvolvement and those without. To the best of our knowledge, this is the first systematic evaluation of nasal involvement in patients with Behcet disease to bepublished in theliterature. Data analysis was performed with Statistical Package for the Social Sciences software (SPSS), anda confidence interval (Cl) at 95% wascalculatedfor each finding. Involvement of the nasal mucosa was seen in 31 of the 400 patients (7.8%; Cl: 5.1 to 10.5). Among those 31 patients, the most common nasalsymptom was dysosmia, which was seen in 15 patients (3.8 % of the totalpopulation; CI: 1.9 to 5.7); other nasal symptoms included obstruction in 10 patients (unilateral in 9), ulcers in 2, pain in 2, and a burningsensation and discharge in 1 each. No patient Introduction Behcet disease was first described in 1937 by Turkish dermatologist Hulusi Behcet as a triple-symptom disease characterized by recurrent oral and genital aphthosis and anterior uveitis with hypopyon. 1 Subsequently, dermatologic and other systemic manifestations of the disease were described. Today Behcet disease is classified as a multisystem disease in the vasculitis group of diseases because its main pathologic feature is a leukocytoclastic vasculitis.P Behcet disease has a particular geographic distribution that is not seen with other systemic diseases.' It is most common in countries along the ancient Silk Road in the Middle East and Southeast Asia.v" It is rare in the Western and Southern Hemispheres.
Among the different manifestations ofBehcet disease, the most common is mucosal aphthosis, which is seen in 97% of affected patients' and which is included in almost all published diagnosis criteria.6-11 Other mucosal lesions such as nonaphthous ulcers and purpuric or hemorrhagic lesions have also been reported. 12 Involvement of mucous layers other than those of the oral and genital areas (e.g., the conjunctiva) has rarely been reported," and only a few cases of nasal mucosal involvement have been report ed.' As a result, the prevalence of nasal mucosal involvement in Behcet disease is not known, and its characteristics have not been delineated. In an effort to add to the available data, we conducted a study to determine the prevalence of nasal mucosal involvement in Behcet disease, to identify its characteristics and their clinical significance, and to determine if there arc any statistically significant differences in clinical and paraclinical parameters between Behcet disease patients with nasal involvement and those without.
Patients and methods
Our study was designed as a descriptive-analytic crosssectional study of all consecutively presenting Behcet disease patients who had been referred to the Behcet's Disease Unit of the Rheumatology Research Center at Shariati Hospital in Tehran. All patients who met the classification-tree criteria described by Davatchi et aPI were enrolled . All patients were question ed for the presence of nasal symptoms, and those who had a history of How do you explain otosclerosis?
How do you show hair cell death?
How do you explain cosmetic procedures? nasal surgery, nasal or sinus diseases, drug addiction, or other connectivetissue diseases were excluded from our analysis.Alleligiblepatients und erwent a complete nasal examination,and furth er complementaryinvestigations were condu cted when indicated. TI1e study wa closed after we had enrolled 400 eligible patient .
For each patient, we collected 78 items of clinical and paraclinical data, and these were analyzed with the Statistical Package for the Social Sciences softwa re ( P S; Chicago). \Ve al 0 calculated 95% confidence interval (CI), means,and standard deviations.Comparisonswere don e by the chi-square test and the Fisher exact test.
Results
TI1e 400 patients included 227 men (57%) and 173 women (43%), for a male-to-female ratio of 1.31:1. Their mean ages at disea eon et were 25.2 year (±9 .7) for the men and 27.5 years (± 10.3) for the women. TI1e most comm on sign at presentation was oral aphthosis, which was seen in 349 patients (87%; CI: 83.7 to 90.7). The prevalence of other initial manifestations of disease was as follows: genital aphtho sis, 35 patients (8.8%; CI:
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(ill) EYEMAGINATIONS l UMR'w O±O the study. This nasal involvement included a history of mucosal ulcers in 51 patients, pain in 49, burning in 32, obstruction in 11 (bilateral in 1), itching in 7, epistaxis in 6, and postnasal discharge in 5. Current nasal mucosal involvement was present in 31 patients (7.8%; CI: 5 to 10.4). The most common nasal symptom was dysosmia, which was seen in 15 patients (3.8% ofthe total population; CI: 1.8 to 5,6); other nasal symptoms included obstruction in 10patients (unilateral in 9), ulcers in 2, pain in 2, and a burning sensation and discharge in 1 each. None ofthese 31 patients reported a history ofepistaxis or nasal itching. Abnormal signs were present in only 16 patients (4.0%; CI: 2.1 to 5.9); they included nasal cartilage deformity in 6, unilateral nasal obstruction in 4, postnasal discharge in 3, nonaphthous ulcer in 3, and crusted ulcer in 2 (2 patients each had 2 abnormal signs). We found no case of aphthous ulcer, nasal discharge, nasal scar or deformity, septal perfora- and cardiopulmonary involve-----------------------------ment, 5 patients (1.3%; CI: 0.3 to 2.3). These findings are similar to the pattern of organ involvement seen in our Behcet disease registry," Although paraclinical evaluation was not done for all patients, the pattern of results was similar to that reported in our previous studyon Behcet disease patients in Iran." Seven paraclinical parameters were measured. The pathergy test was positive in 45% ofpatients (CI: 42 to 48.6), HLA-B5 was positive in 50% (CI : 47.9 to 52.9), HLA-B51 was positive in 42% (CI: 33.6 to 50.2), and HLA-B27 was positive in 6.4% (CI: 3.9 to 8.9). Among tested patients, a high erythrocyte sedimentation rate (~20 mm in the first hour) was seen in 51% (CI: 48.6 to 53.2), a urine abnormality in 6.2% (CI: 3.8 to 8.6), and a false-positive syphilis test in 1.1% (CI: 0.1 to 2.1).
Of the 400 patients, 67 (17%; CI: 13 to 20.4) had a history of nasal mucosal involvement, although nasal involvement was not present in all ofthem at the time of Data analysis revealed no statistically significant differences in any of the 10 clinical manifestations between patients with and without nasal mucosal involvement (table 1) . Nor were there any significant differences between the two groups with respect to the 7 paraclinical parameters (table 2) .
Discussion
Nasal (notably mucosal) involvement has been reported in various vasculitic and connective tissue diseases, such as Wegener granulomatosis,14Churg-Strauss syndrome,15 systemic lupus erythematosus, 16, 17 Sjogren syndrome, 18 systemic sclerosis,'? and relapsing polychondritis." But until now, there has been no report on the prevalence and characteristics of nasal mucosal involvement in Behcet disease, despite its importance to the diagnosis.' To the best of our knowledge, our study represents the first systematic evaluation of nasal involvement in patients with Behcet disease. It revealed that nasal involvement is not common in Behcetdisease, and that nasal ulcers are rare (only 2 in our patient population). On the other hand, oral and genital mucosal involvement in Behcet disease is common.r" The differences in the rates of mucosal involvement by site may be attributable to the histologic differences between the nasal mucosa and other mucosae; if so, this would suggest that local tissue factors might playa role in the pathogenesis of Behcet disease. Further studies are needed to test this hypothesis.
We did not classify all patients who had a history of "nasal complaints" as having "nasal involvement" because not all of these complaints had been evaluated by a physician and therefore definitive diagnoses were not established. Because most of the clinical manifestations ofBehcetdisease (including mucosal involvement) are generally transient and self-Itmlting.t' it is quite probable that we underestimated the prevalence of nasal involvement in our patients. If we had included in our study all 81 patients who had a history of nasal complaints as well as a current symptom or sign, the incidence of nasal involvement would have risen to 20% (CI: 16.3 to 24.l).
In conclusion, we found no apparent relationship between nasal mucosal involvement and any clinical or paraclinical findings in Behcet disease, as we could not show any statistically significant difference when comparing these parameters in patients with and without nasal mucosal involvement. Volume 89, Number 1
